Status:

COMPLETED

Evaluation of Metionac for the Modulation of Metabolic and Endocrine Parameters in Patients With PCOS.

Lead Sponsor:

Margan Biotech

Collaborating Sponsors:

Grupo CINUSA (Centros de Investigación en Nutrición y Salud S.L.)

Conditions:

Polycystic Ovary Syndrome

Eligibility:

FEMALE

18+ years

Phase:

PHASE4

Brief Summary

Evaluate the efficacy of the combination of antioxidants ALA, NAC, Vit. B6 and SAMe as a dietary supplement, in the improvement of metabolic and endocrine parameters and clinical manifestations of PCO...

Detailed Description

The investigators will explain the study to all patients who meet the inclusion and exclusion criteria during the study period. After signing the informed consent patients will be randomized 1:1 to or...

Eligibility Criteria

Inclusion

  • Women newly diagnosed with PCOS with at least 2 of the following symptoms:
  • Oligo/Anovulation \< 21 or \> 35 days \> 90 days (any cycle) \< 8 periods / year
  • Hyperandrogenism (clinical symptoms or laboratory results)
  • Polycystic ovary morphology (NHMRC guideline): In any ovary:
  • 20 follicles\* and/or ovarian volume greater than or equal to 10ml and no corpus luteum, cysts or dominant follicles
  • \*number of follicles per ovary measuring 2-9 mm
  • \> 18 years old
  • Overweight defined as BMI\>25
  • Normal prolactin levels
  • Women with altered coagulation factors or a personal history of thromboembolism for whom OAC is contraindicated (they will be included in the control group without randomization)
  • Written inform consent

Exclusion

  • Diabetic women
  • Adrenal enzyme deficiency and/or other endocrine disease
  • Pregnant or lactating women.
  • Women under treatment with SNRIs (serotonin reuptake inhibitors)
  • Other serious illness

Key Trial Info

Start Date :

April 20 2020

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

February 2 2022

Estimated Enrollment :

90 Patients enrolled

Trial Details

Trial ID

NCT05340634

Start Date

April 20 2020

End Date

February 2 2022

Last Update

April 28 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Hospital Quironsalud San José

Madrid, Spain